Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas U Marron

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Nature Cancer|July 27, 2023
SIGLEC9 tips the myeloid balance in glioblastomaThomas U Marron, Jennifer L Guerriero
Radiology|January 11, 2022
Is There an Impact of Locoregional Therapy on Immune Response Modulation in HCC?Paul Kennedy, Thomas U Marron, Bachir Taouli
Current Hematologic Malignancy Reports|July 24, 2017
An Update on the Use of Immunotherapy in the Treatment of LymphomaThomas U Marron, Matko Kalac, Joshua Brody
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2015
Diagnostic utility of measuring free light chains in the cerebrospinal fluid of patients with multiple myelomaThomas U Marron, Lakshmi Ramanathan, Ajai Chari
Gastrointestinal Endoscopy|September 16, 2014
Barriers to colonoscopy among New York City homelessThomas U Marron, Amy Weiner, Mark Rabiner
JAMA Oncology|May 7, 2026
Reassessing Treatment Outcomes Following Immune-Related Adverse Events-ReplyBrandon R Block, Thomas U Marron, Nicholas Gulati
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Toll-like receptor function in primary B cell defectsThomas U Marron, Joyce E Yu, Charlotte Cunningham-Rundles
Journal of Hepatocellular Carcinoma|July 7, 2022
Neoadjuvant Immunotherapy for Hepatocellular CarcinomaThomas U Marron, Myron Schwartz, Virginia Corbett, et al.
JAMA Oncology|May 21, 2026
A Dermatologist's Perspective on Cutaneous Adverse Effects in CTCAE Version 6.0Nicholas Gulati, Brandon R Block, Jaanvi Mehta, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 29, 2016
Validation and Utility of the Free Light Chain Assay in Pleural Effusions of Patients With Multiple MyelomaThomas U Marron, Matthew G Hanna, Lakshmi Ramanathan, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Nature Cancer|July 27, 2023
SIGLEC9 tips the myeloid balance in glioblastomaThomas U Marron, Jennifer L Guerriero
Radiology|January 11, 2022
Is There an Impact of Locoregional Therapy on Immune Response Modulation in HCC?Paul Kennedy, Thomas U Marron, Bachir Taouli
Current Hematologic Malignancy Reports|July 24, 2017
An Update on the Use of Immunotherapy in the Treatment of LymphomaThomas U Marron, Matko Kalac, Joshua Brody
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2015
Diagnostic utility of measuring free light chains in the cerebrospinal fluid of patients with multiple myelomaThomas U Marron, Lakshmi Ramanathan, Ajai Chari
Gastrointestinal Endoscopy|September 16, 2014
Barriers to colonoscopy among New York City homelessThomas U Marron, Amy Weiner, Mark Rabiner
JAMA Oncology|May 7, 2026
Reassessing Treatment Outcomes Following Immune-Related Adverse Events-ReplyBrandon R Block, Thomas U Marron, Nicholas Gulati
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Toll-like receptor function in primary B cell defectsThomas U Marron, Joyce E Yu, Charlotte Cunningham-Rundles
Journal of Hepatocellular Carcinoma|July 7, 2022
Neoadjuvant Immunotherapy for Hepatocellular CarcinomaThomas U Marron, Myron Schwartz, Virginia Corbett, et al.
JAMA Oncology|May 21, 2026
A Dermatologist's Perspective on Cutaneous Adverse Effects in CTCAE Version 6.0Nicholas Gulati, Brandon R Block, Jaanvi Mehta, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 29, 2016
Validation and Utility of the Free Light Chain Assay in Pleural Effusions of Patients With Multiple MyelomaThomas U Marron, Matthew G Hanna, Lakshmi Ramanathan, et al.
Pageof 10